Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
Paul Toren(Hôtel-Dieu de Québec), Amina Zoubeidi(University of British Columbia)
Cited by 158
Related Papers
Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD
|Cancer Research|2010|101
RETRACTED: Hsp27 regulates EGF/β‐catenin mediated epithelial to mesenchymal transition in prostate cancer
|International Journal of Cancer|2014|67
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer
|Oncotarget|2015|44